NovoCure Limited (NVCR) Q1 2026 Earnings Call April 30, 2026 8:00 AM EDT
Company Participants
Adam Daney – Head of Investor Relations
William Doyle – Executive Chairman
Frank Leonard – Chief Executive Officer
Christoph Brackmann – Chief Financial Officer
Uri Weinberg – Chief Innovation Officer & Chief Medical Officer
Conference Call Participants
Jonathan Chang – Leerink Partners LLC, Research Division
Jason Bednar – Piper Sandler & Co., Research Division
Kevin DeGeeter – Ladenburg Thalmann & Co. Inc., Research Division
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Emily Bodnar – H.C. Wainwright & Co, LLC, Research Division
Tanmay Patwardhan
Presentation
Operator
Good day, and thank you for standing by. Welcome to the NovoCure’s Q1 2026 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Adam Daney. Please go ahead.
Adam Daney
Head of Investor Relations
Good morning, and thank you for joining us to review NovoCure’s First Quarter 2026 financial performance. I’m joined on the phone today with our Executive Chairman, Bill Doyle; CEO, Frank Leonard; Chief Innovation and Medical Officer, Uri Weinberg; and CFO, Christoph Brackmann. Other members of our executive leadership team will be available for Q&A. For your reference, slides accompanying this earnings release can be found on our website, novocure.com on the Investor Relations page under Quarterly Reports.
Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements, and actual results could differ materially from those projected in these statements. These statements involve a number of risks and uncertainties, some of which are beyond our control and are described from time to time in our SEC filings. We do not intend to update publicly any forward-looking statements, except as required by law.
